BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 20, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 2013

View Archived Issues

Bivalent norovirus vaccine protects against illness in oral challenge study

Read More

Varicella zoster vaccine candidate is immunogenic in patients with HIV infection

Read More

CD151 antigen expression correlated with progression in advanced gastric cancer

Read More

Bioengineering of a novel nanotechnology-based drug delivery system

Read More

Rational computational design of high-affinity, small-molecule-selective binding proteins

Read More

Anxiolytic activity demonstrated for RU-476

Read More

Mesoblast acquires Osiris' culture-expanded mesenchymal stem cell business

Read More

Novel photoimmunoconjugates discovered by German group

Read More

Researchers disclose new monoclonal antibodies for cancer and ocular disorders

Read More

Takeda Pharmaceutical prepares novel GL-R antagonists for diabetes

Read More

CCI Corporation patents new agents for cancer

Read More

New Aurora kinase inhibitors synthesized at Sunshine Lake Pharma

Read More

Clavis Pharma becomes Aqualis

Read More

Alcobra presents new findings on MG-01CI

Read More

Protalix BioTherapeutics reports phase I data for PRX-112

Read More

MannKind resubmits Afrezza NDA

Read More

Topline data from phase II TRUST-I trial in Crohn's disease reported

Read More

FDA releases drug safety communication for ponatinib

Read More

Otrexup injection approved by the FDA for several indications

Read More

Cellceutix plans to begin phase IIb trial of Brilacidin in 2014

Read More

Boehringer Ingelheim and Lilly submit application in Japan for empagliflozin

Read More

Acacia Pharma's phase II trial of APD-515 for xerostomia meets primary endpoint

Read More

Immatics raises funds to complete development of IMA-901 for renal cancer

Read More

Janssen files MAA with EMA for fixed-dose combination of darunavir and cobicistat

Read More

MedImmune acquires biotech company and invests in ADC Therapeutics

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing